GH - CIK 0001576280
Guardant Health, Inc. (GH) reported revenue of $982.02M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $982.02M | +32.9% |
| FY 2024 | $739.02M | +31.0% |
| FY 2023 | $563.95M | +25.5% |
| FY 2022 | $449.54M | +20.3% |
| FY 2021 | $373.65M | +30.3% |
| FY 2020 | $286.73M | +33.8% |
| FY 2019 | $214.38M | +136.5% |
| FY 2018 | $90.64M | +81.9% |
| FY 2017 |
Guardant Health, Inc. (GH) reported revenue of $982.02M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2016 and fiscal 2025, Guardant Health, Inc.'s revenue grew from $25.25M to $982.02M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $49.84M |
| +97.4% |
| FY 2016 | $25.25M | - |